Safety and efficacy of dolutegravir-based ART in TB/HIV coinfected adults at week 48

Category Primary study
ConferenceJournal of the International AIDS Society
Year 2019
This article has no abstract
Epistemonikos ID: c0a35a86bcb691955693762aedbacad0ecc654b2
First added on: Apr 30, 2026